Skip to content

Clinical trials

Observational Cardiomyopathy, Hypertrophic trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Hypertrophic Phase: Observational Country / region: United Kingdom Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20152
20182
20191
20211
20221
20232
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Completed3
Active, not recruiting2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb2
Imperial College London2
University of Edinburgh2
University of Manchester2
Christopher Kramer1
Guy's and St Thomas' NHS Foundation Trust1
Pfizer1
Tenaya Therapeutics1
University College, London1
University of Virginia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Hypertrophic15
Cardiomyopathy, Dilated4
Cardiomyopathies3
Myocarditis2
Atrial Fibrillation1
Cardiomyopathy, Restrictive1
Cardiovascular Diseases1
Heart Failure1
Long QT Syndrome1
Takotsubo Cardiomyopathy1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.